Literature DB >> 18756298

Response to 'Tacrolimus in membranous nephropathy'.

Manuel Praga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18756298     DOI： 10.1038/ki.2008.276

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  3 in total

Review 1.  Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care?

Authors:  Lee A Hebert; Brad H Rovin
Journal:  Nephron Clin Pract       Date:  2010-08-03

Review 2.  Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.

Authors:  Agnieszka Pozdzik; Isabelle Brochériou; Cristina David; Fahd Touzani; Jean Michel Goujon; Karl Martin Wissing
Journal:  Biomed Res Int       Date:  2018-01-08       Impact factor: 3.411

3.  Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and Cyclophosphamide.

Authors:  Raja Ramachandran; Ashok Kumar Yadav; Vinod Kumar; Venkata Siva Tez Pinnamaneni; Ritambhra Nada; Ratan Ghosh; Vivek Kumar; Manish Rathi; Harbir Singh Kohli; Krishan Lal Gupta; Vinay Sakhuja; Vivekanand Jha
Journal:  Kidney Int Rep       Date:  2017-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.